ReviewRadiologic clinics of North America2016
Imaging of Hypersensitivity Pneumonitis.
Review in Radiologic clinics of North America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 45 citations in OpenAlex.
- Quality of AI chatbot-generated information on hypersensitivity pneumonitis for clinical and patient use.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2026Article
- The diagnostic contribution of bronchoalveolar lavage to lung cryo-transbronchial biopsy in interstitial lung diseases.BMC pulmonary medicine · 2025Article
- The effectiveness and pharmacoeconomic study of using different corticosteroids in the treatment of hypersensitivity pneumonitis.BMC pulmonary medicine · 2024Article
- Noninfectious Granulomatous Lung Disease: Radiological Findings and Differential Diagnosis.Journal of personalized medicine · 2024Review
- Hypersensitivity Pneumonia Due to Lentil Aspiration: A Rare but Painstaking Pulmonary Illness.Global pediatric health · 2024Article
- Lung consolidation in a young-age active smoker: An unexpected diagnosis.Respiratory medicine case reports · 2024Article
- Evaluation of cases with hypersensitivity pneumonia: 10 year analysis.The clinical respiratory journal · 2023Article
- Features of transbronchial lung cryobiopsy-diagnosed fibrotic hypersensitivity pneumonitis.The clinical respiratory journal · 2023Article
- Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2022Article
- Ground-glass opacity (GGO): a review of the differential diagnosis in the era of COVID-19.Japanese journal of radiology · 2021Review
- Non-Infectious Granulomatous Lung Disease: Imaging Findings with Pathologic Correlation.Korean journal of radiology · 2021Review
- Article
- Mimickers of novel coronavirus disease 2019 (COVID-19) on chest CT: spectrum of CT and clinical features.Insights into imaging · 2021Review
- The Role of Radiology in Progressive Fibrosing Interstitial Lung Disease.Frontiers in medicine · 2021Review
- Rare imaging findings of hypersensitivity pneumonitis: A case report.World journal of clinical cases · 2020Article
- Practical guide for pediatric pulmonologists on imaging management of pediatric patients with COVID-19.Pediatric pulmonology · 2020Review
- A Pathophysiological Perspective on COVID-19's Lethal Complication: From Viremia to Hypersensitivity Pneumonitis-like Immune Dysregulation.Infection & chemotherapy · 2020Review
- When pneumonia is not COVID-19.RadiologiaReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
The management of hypersensitivity pneumonitis (HP) depends on early identification of the disease process, which is complicated by its nonspecific clinical presentation in addition to variable and diverse laboratory and radiologic findings. HP is the result of exposure and sensitization to myriad aerosolized antigens. HP develops in the minority of antigenic exposures, and conversely has been documented in patients with no identifiable exposure, complicating the diagnostic algorithm significantly. Prompt diagnosis and early intervention are critical in slowing the progression of irreversible parenchymal damage, and additionally in preserving the quality of life of affected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.